{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T18:40:29Z","timestamp":1742496029593,"version":"3.40.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Johns Hopkins in Health"},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL131812","K23HL155507"],"award-info":[{"award-number":["R01HL131812","K23HL155507"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sherrilyn and Ken Fisher Center for Environmental Infectious Diseases"},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["2U18FD005320"],"award-info":[{"award-number":["2U18FD005320"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["U54EB007958"],"award-info":[{"award-number":["U54EB007958"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Parker B. Francis Foundation"},{"name":"Johns Hopkins University COVID-19 Research Response Program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-94024-y","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T18:21:32Z","timestamp":1742494892000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of antecedent B-cell depletion therapy for patients hospitalized with COVID-19 within a single health system: a propensity score analysis"],"prefix":"10.1038","volume":"15","author":[{"given":"William M.","family":"Garneau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunbo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanxun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas E.","family":"Gladstone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin K.","family":"Avery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco R.","family":"D\u2019Alessio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew L.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarina K.","family":"Sahetya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian T.","family":"Garibaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly A.","family":"Gebo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Veronica","family":"Dioverti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,20]]},"reference":[{"issue":"11","key":"94024_CR1","doi-asserted-by":"publisher","first-page":"e0241824","DOI":"10.1371\/journal.pone.0241824","volume":"15","author":"FK Ho","year":"2020","unstructured":"Ho, F. K. et al. Is older age associated with COVID-19 mortality in the absence of other risk factors? General population cohort study of 470,034 participants. PLoS ONE 15(11), e0241824. https:\/\/doi.org\/10.1371\/journal.pone.0241824 (2020).","journal-title":"PLoS ONE"},{"issue":"7","key":"94024_CR2","doi-asserted-by":"publisher","first-page":"e0254066","DOI":"10.1371\/journal.pone.0254066","volume":"16","author":"NT Nguyen","year":"2021","unstructured":"Nguyen, N. T. et al. Male gender is a predictor of higher mortality in hospitalized adults with COVID-19. PLoS ONE 16(7), e0254066. https:\/\/doi.org\/10.1371\/journal.pone.0254066 (2021).","journal-title":"PLoS ONE"},{"issue":"10","key":"94024_CR3","doi-asserted-by":"publisher","first-page":"355","DOI":"10.15585\/mmwr.mm7010e4","volume":"70","author":"L Kompaniyets","year":"2021","unstructured":"Kompaniyets, L. et al. Body mass index and risk for COVID-19\u2013related hospitalization, intensive care unit admission, invasive mechanical ventilation, and death\u2014United States, March\u2013December 2020. MMWR Morb. Mortal. Wkly. Rep. 70(10), 355\u2013361. https:\/\/doi.org\/10.15585\/mmwr.mm7010e4 (2021).","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"7","key":"94024_CR4","doi-asserted-by":"publisher","first-page":"e0270763","DOI":"10.1371\/journal.pone.0270763","volume":"17","author":"R Poudel","year":"2022","unstructured":"Poudel, R. et al. Smoking is associated with increased risk of cardiovascular events, disease severity, and mortality among patients hospitalized for SARS-CoV-2 infections. PLOS ONE 17(7), e0270763. https:\/\/doi.org\/10.1371\/journal.pone.0270763 (2022).","journal-title":"PLOS ONE"},{"issue":"1","key":"94024_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1136\/annrheumdis-2019-215882","volume":"79","author":"V Furer","year":"2020","unstructured":"Furer, V. et al. 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann. Rheum. Dis. 79(1), 39\u201352. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215882 (2020).","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"94024_CR6","doi-asserted-by":"publisher","first-page":"e269","DOI":"10.1097\/TP.0000000000004090","volume":"106","author":"J Mitchell","year":"2022","unstructured":"Mitchell, J. et al. Effect of mycophenolate mofetil dosing on antibody response to SARS-CoV-2 vaccination in heart and lung transplant recipients. Transplantation 106(5), e269\u2013e270. https:\/\/doi.org\/10.1097\/TP.0000000000004090 (2022).","journal-title":"Transplantation"},{"issue":"9","key":"94024_CR7","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.7326\/M21-1451","volume":"174","author":"CM Connolly","year":"2021","unstructured":"Connolly, C. M. et al. Absence of humoral response after two-dose SARS-CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal diseases: A case series. Ann. Intern. Med. 174(9), 1332\u20131334. https:\/\/doi.org\/10.7326\/M21-1451 (2021).","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"94024_CR8","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/acr2.11386","volume":"4","author":"NJ Patel","year":"2022","unstructured":"Patel, N. J. et al. Coronavirus disease 2019 outcomes among recipients of ANTI-CD20 monoclonal antibodies for immune-mediated diseases: A comparative cohort study. ACR Open Rheumatol. 4(3), 238\u2013246. https:\/\/doi.org\/10.1002\/acr2.11386 (2022).","journal-title":"ACR Open Rheumatol."},{"issue":"6","key":"94024_CR9","doi-asserted-by":"publisher","first-page":"e419","DOI":"10.1016\/S2665-9913(21)00059-X","volume":"3","author":"J Avouac","year":"2021","unstructured":"Avouac, J. et al. COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: A cohort study. Lancet Rheumatol. 3(6), e419\u2013e426. https:\/\/doi.org\/10.1016\/S2665-9913(21)00059-X (2021).","journal-title":"Lancet Rheumatol."},{"issue":"7","key":"94024_CR10","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1136\/annrheumdis-2020-219498","volume":"80","author":"A Strangfeld","year":"2021","unstructured":"Strangfeld, A. et al. Factors associated with COVID-19-related death in people with rheumatic diseases: Results from the COVID-19 global rheumatology alliance physician-reported registry. Ann. Rheum. Dis. 80(7), 930\u2013942. https:\/\/doi.org\/10.1136\/annrheumdis-2020-219498 (2021).","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"94024_CR11","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1136\/annrheumdis-2021-220418","volume":"80","author":"JA Sparks","year":"2021","unstructured":"Sparks, J. A. et al. Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 global rheumatology alliance physician registry. Ann. Rheum. Dis. 80(9), 1137\u20131146. https:\/\/doi.org\/10.1136\/annrheumdis-2021-220418 (2021).","journal-title":"Ann. Rheum. Dis."},{"issue":"11","key":"94024_CR12","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1007\/s00277-021-04662-1","volume":"100","author":"H Levavi","year":"2021","unstructured":"Levavi, H., Lancman, G. & Gabrilove, J. Impact of rituximab on COVID-19 outcomes. Ann. Hematol. 100(11), 2805\u20132812. https:\/\/doi.org\/10.1007\/s00277-021-04662-1 (2021).","journal-title":"Ann. Hematol."},{"issue":"10","key":"94024_CR13","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1093\/cid\/ciab700","volume":"74","author":"J Calder\u00f3n-Parra","year":"2022","unstructured":"Calder\u00f3n-Parra, J. et al. Incidence, clinical presentation, relapses and outcome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in patients treated with anti-CD20 monoclonal antibodies. Clin. Infect. Dis. 74(10), 1786\u20131794. https:\/\/doi.org\/10.1093\/cid\/ciab700 (2022).","journal-title":"Clin. Infect. Dis."},{"issue":"8","key":"94024_CR14","doi-asserted-by":"publisher","first-page":"e192","DOI":"10.1016\/S1473-3099(20)30483-7","volume":"20","author":"JC Marshall","year":"2020","unstructured":"Marshall, J. C. et al. A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect. Dis. 20(8), e192\u2013e197. https:\/\/doi.org\/10.1016\/S1473-3099(20)30483-7 (2020).","journal-title":"Lancet Infect. Dis."},{"issue":"23","key":"94024_CR15","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1001\/jama.2020.7819","volume":"323","author":"LE Thomas","year":"2020","unstructured":"Thomas, L. E., Li, F. & Pencina, M. J. Overlap weighting: A propensity score method that mimics attributes of a randomized clinical trial. JAMA 323(23), 2417. https:\/\/doi.org\/10.1001\/jama.2020.7819 (2020).","journal-title":"JAMA"},{"key":"94024_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwy201","author":"F Li","year":"2018","unstructured":"Li, F. & Thomas, L. E. Addressing extreme propensity scores via the overlap weights. Am. J. Epidemiol. https:\/\/doi.org\/10.1093\/aje\/kwy201 (2018).","journal-title":"Am. J. Epidemiol."},{"issue":"521","key":"94024_CR17","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1080\/01621459.2016.1260466","volume":"113","author":"F Li","year":"2018","unstructured":"Li, F., Morgan, K. L. & Zaslavsky, A. M. Balancing covariates via propensity score weighting. J. Am. Stat. Assoc. 113(521), 390\u2013400. https:\/\/doi.org\/10.1080\/01621459.2016.1260466 (2018).","journal-title":"J. Am. Stat. Assoc."},{"key":"94024_CR18","unstructured":"R Core Team. R: A language and environment for statistical computing. Published online 2020. https:\/\/www.R-project.org\/"},{"issue":"3","key":"94024_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.5501\/wjv.v10.i3.97","volume":"10","author":"JC Riches","year":"2021","unstructured":"Riches, J. C. Impact of COVID-19 in patients with lymphoid malignancies. World J. Virol. 10(3), 97\u2013110. https:\/\/doi.org\/10.5501\/wjv.v10.i3.97 (2021).","journal-title":"World J. Virol."},{"issue":"25","key":"94024_CR20","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1182\/blood.2020008824","volume":"136","author":"A Vijenthira","year":"2020","unstructured":"Vijenthira, A. et al. Outcomes of patients with hematologic malignancies and COVID-19: A systematic review and meta-analysis of 3377 patients. Blood 136(25), 2881\u20132892. https:\/\/doi.org\/10.1182\/blood.2020008824 (2020).","journal-title":"Blood"},{"key":"94024_CR21","doi-asserted-by":"publisher","first-page":"100549","DOI":"10.1016\/j.eclinm.2020.100549","volume":"27","author":"S Lamure","year":"2020","unstructured":"Lamure, S. et al. Determinants of outcome in Covid-19 hospitalized patients with lymphoma: A retrospective multicentric cohort study. EClinicalMedicine 27, 100549. https:\/\/doi.org\/10.1016\/j.eclinm.2020.100549 (2020).","journal-title":"EClinicalMedicine"},{"issue":"3","key":"94024_CR22","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1097\/HS9.0000000000000538","volume":"5","author":"I Regalado-Artamendi","year":"2021","unstructured":"Regalado-Artamendi, I. et al. Risk factors and mortality of COVID-19 in patients with lymphoma: A multicenter study. HemaSphere 5(3), e538. https:\/\/doi.org\/10.1097\/HS9.0000000000000538 (2021).","journal-title":"HemaSphere"},{"issue":"4","key":"94024_CR23","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/ana.26028","volume":"89","author":"MP Sormani","year":"2021","unstructured":"Sormani, M. P. et al. Disease-modifying therapies and coronavirus disease 2019 severity in multiple sclerosis. Ann. Neurol. 89(4), 780\u2013789. https:\/\/doi.org\/10.1002\/ana.26028 (2021).","journal-title":"Ann. Neurol."},{"issue":"1","key":"94024_CR24","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1016\/S2665-9913(21)00325-8","volume":"4","author":"KM Andersen","year":"2022","unstructured":"Andersen, K. M. et al. Long-term use of immunosuppressive medicines and in-hospital COVID-19 outcomes: A retrospective cohort study using data from the National COVID Cohort Collaborative. Lancet Rheumatol. 4(1), e33\u2013e41. https:\/\/doi.org\/10.1016\/S2665-9913(21)00325-8 (2022).","journal-title":"Lancet Rheumatol."},{"issue":"6","key":"94024_CR25","doi-asserted-by":"publisher","first-page":"e417","DOI":"10.1016\/S2665-9913(22)00102-3","volume":"4","author":"L Boekel","year":"2022","unstructured":"Boekel, L. et al. Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: A substudy of two prospective cohort studies. Lancet Rheumatol. 4(6), e417\u2013e429. https:\/\/doi.org\/10.1016\/S2665-9913(22)00102-3 (2022).","journal-title":"Lancet Rheumatol."},{"issue":"2","key":"94024_CR26","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1136\/annrheumdis-2021-221326","volume":"81","author":"C Cook","year":"2022","unstructured":"Cook, C. et al. Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases. Ann. Rheum. Dis. 81(2), 289\u2013291. https:\/\/doi.org\/10.1136\/annrheumdis-2021-221326 (2022).","journal-title":"Ann. Rheum. Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94024-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94024-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94024-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T18:21:41Z","timestamp":1742494901000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94024-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,20]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["94024"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-94024-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,20]]},"assertion":[{"value":"4 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was performed in accordance with the Declaration of Helsinki and was approved under protocol IRB00283579 by the Johns Hopkins University School of Medicine Institutional Review Board. The need to obtain informed consent was waived by the Johns Hopkins University School of Medicine Institutional Review Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Due to the retrospective nature of the study, Johns Hopkins University School of Medicine Institutional Review Board waived the need of obtaining informed consent. Data for the study publication was obtained from protocol IRB00247569 which maintains current IRB approval and was included under a waiver of consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"9647"}}